Health
Vaccine makers including Moderna must hit US timing goals for full payments – CNA
The United States is tying payments for COVID-19 vaccines to timing milestones for production and approval, according to public documents and a Trump administration official, putting pressure on drugmakers including Moderna Inc to meet ambitious targets.
NEW YORK: The United States is tying payments for COVID-19 vaccines to timing milestones for production and approval, according to public documents and a Trump administration official, putting pressure on drugmakers including Moderna to meet ambitious targets.
In a deal with Moderna announced this week, federal agencies negotiated a sliding scale of payments. The Cambridge, Massachusetts, biotech’s US$1.5-billion deal pays out in full if its vaccine receives regulatory clearance by Jan 31, 2021…
-
Noosa News23 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
General23 hours agoAustralia retains Chappell-Hadlee Trophy after rain washes out second T20I against New Zealand
-
General22 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General22 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation